487 related articles for article (PubMed ID: 22580248)
1. First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions.
Onsea K; Agostoni P; Samim M; Voskuil M; Kluin J; Budde R; Hendrikse J; Ramjankhan F; van Klarenbosch J; Doesburg P; Sieswerda G; Stella P
EuroIntervention; 2012 May; 8(1):51-6. PubMed ID: 22580248
[TBL] [Abstract][Full Text] [Related]
2. An embolic deflection device for aortic valve interventions.
Nietlispach F; Wijesinghe N; Gurvitch R; Tay E; Carpenter JP; Burns C; Wood DA; Webb JG
JACC Cardiovasc Interv; 2010 Nov; 3(11):1133-8. PubMed ID: 21087748
[TBL] [Abstract][Full Text] [Related]
3. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation.
Naber CK; Ghanem A; Abizaid AA; Wolf A; Sinning JM; Werner N; Nickenig G; Schmitz T; Grube E
EuroIntervention; 2012 May; 8(1):43-50. PubMed ID: 22403768
[TBL] [Abstract][Full Text] [Related]
4. Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study.
Baumbach A; Mullen M; Brickman AM; Aggarwal SK; Pietras CG; Forrest JK; Hildick-Smith D; Meller SM; Gambone L; den Heijer P; Margolis P; Voros S; Lansky AJ
EuroIntervention; 2015 May; 11(1):75-84. PubMed ID: 25868876
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study.
Rodés-Cabau J; Kahlert P; Neumann FJ; Schymik G; Webb JG; Amarenco P; Brott T; Garami Z; Gerosa G; Lefèvre T; Plicht B; Pocock SJ; Schlamann M; Thomas M; Diamond B; Merioua I; Beyersdorf F; Vahanian A
JACC Cardiovasc Interv; 2014 Oct; 7(10):1146-55. PubMed ID: 25341709
[TBL] [Abstract][Full Text] [Related]
6. TriGuard
Samim M; van der Worp B; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Ramjankhan F; Doevendans PA; Stella PR
Catheter Cardiovasc Interv; 2017 Feb; 89(3):470-477. PubMed ID: 27121306
[TBL] [Abstract][Full Text] [Related]
7. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging.
Ghanem A; Müller A; Nähle CP; Kocurek J; Werner N; Hammerstingl C; Schild HH; Schwab JO; Mellert F; Fimmers R; Nickenig G; Thomas D
J Am Coll Cardiol; 2010 Apr; 55(14):1427-32. PubMed ID: 20188503
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status.
Fairbairn TA; Mather AN; Bijsterveld P; Worthy G; Currie S; Goddard AJ; Blackman DJ; Plein S; Greenwood JP
Heart; 2012 Jan; 98(1):18-23. PubMed ID: 21737581
[TBL] [Abstract][Full Text] [Related]
9. Embrella embolic deflection device for cerebral protection during transcatheter aortic valve replacement.
Samim M; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Kluin J; Ramjankhan F; Doevendans PA; Stella PR
J Thorac Cardiovasc Surg; 2015 Mar; 149(3):799-805.e1-2. PubMed ID: 25455466
[TBL] [Abstract][Full Text] [Related]
10. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients.
Eggebrecht H; Schmermund A; Voigtländer T; Kahlert P; Erbel R; Mehta RH
EuroIntervention; 2012 May; 8(1):129-38. PubMed ID: 22391581
[TBL] [Abstract][Full Text] [Related]
11. Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging.
Arnold M; Schulz-Heise S; Achenbach S; Ott S; Dörfler A; Ropers D; Feyrer R; Einhaus F; Loders S; Mahmoud F; Roerick O; Daniel WG; Weyand M; Ensminger SM; Ludwig J
JACC Cardiovasc Interv; 2010 Nov; 3(11):1126-32. PubMed ID: 21087747
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation: comparison of transfemoral and trans-apical approaches using Edwards Sapiens valve.
Astarci P; Glineur D; Kefer J; D'Hoore W; Renkin J; Vanoverschelde JL; El Khoury G; Grandin C
Eur J Cardiothorac Surg; 2011 Aug; 40(2):475-9. PubMed ID: 21256045
[TBL] [Abstract][Full Text] [Related]
13. Safety and feasibility of a novel transcervical access neuroprotection system for carotid artery stenting in the PROOF Study.
Pinter L; Ribo M; Loh C; Lane B; Roberts T; Chou TM; Kolvenbach RR
J Vasc Surg; 2011 Nov; 54(5):1317-23. PubMed ID: 21658889
[TBL] [Abstract][Full Text] [Related]
14. Histopathology of embolic debris captured during transcatheter aortic valve replacement.
Van Mieghem NM; Schipper ME; Ladich E; Faqiri E; van der Boon R; Randjgari A; Schultz C; Moelker A; van Geuns RJ; Otsuka F; Serruys PW; Virmani R; de Jaegere PP
Circulation; 2013 Jun; 127(22):2194-201. PubMed ID: 23652860
[TBL] [Abstract][Full Text] [Related]
15. Single center experience with transcatheter aortic valve implantation using the Edwards SAPIEN™ Valve.
Nielsen HH; Thuesen L; Egeblad H; Poulsen SH; Klaaborg KE; Jakobsen CJ; Andersen HR; Hjortdal VE
Scand Cardiovasc J; 2011 Oct; 45(5):261-6. PubMed ID: 21506661
[TBL] [Abstract][Full Text] [Related]
16. Performance of valve-in-valve for severe para-prosthetic leaks due to inadequate transcatheter aortic valve implantation.
Napodano M; Gasparetto V; Tarantini G; Fraccaro C; Yzeiraj E; Gerosa G; Isabella G; Iliceto S
Catheter Cardiovasc Interv; 2011 Dec; 78(7):996-1003. PubMed ID: 22114036
[TBL] [Abstract][Full Text] [Related]
17. First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.
Latib A; Mangieri A; Vezzulli P; Spagnolo P; Sardanelli F; Fellegara G; Pagnesi M; Giannini F; Falini A; Gorla R; Montorfano M; Bedogni F; Colombo A; Popma J; Merhi WM; De Marco F
JACC Cardiovasc Interv; 2020 Apr; 13(7):860-868. PubMed ID: 32273098
[TBL] [Abstract][Full Text] [Related]
18. Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis: The CLEAN-TAVI Randomized Clinical Trial.
Haussig S; Mangner N; Dwyer MG; Lehmkuhl L; Lücke C; Woitek F; Holzhey DM; Mohr FW; Gutberlet M; Zivadinov R; Schuler G; Linke A
JAMA; 2016 Aug; 316(6):592-601. PubMed ID: 27532914
[TBL] [Abstract][Full Text] [Related]
19. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches.
Rodés-Cabau J; Dumont E; Boone RH; Larose E; Bagur R; Gurvitch R; Bédard F; Doyle D; De Larochellière R; Jayasuria C; Villeneuve J; Marrero A; Côté M; Pibarot P; Webb JG
J Am Coll Cardiol; 2011 Jan; 57(1):18-28. PubMed ID: 21185496
[TBL] [Abstract][Full Text] [Related]
20. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry.
Bosmans JM; Kefer J; De Bruyne B; Herijgers P; Dubois C; Legrand V; Verheye S; Rodrigus I;
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):762-7. PubMed ID: 21349890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
